摘要
目的调查本院尖吻蝮蛇血凝酶临床应用情况,为临床合理用药提供依据。方法抽取本院2019年1~6月使用尖吻蝮蛇血凝的住院病历共963份,填写点评处方登记表,评价用药合理性。结果用药不合理病历共356份,占总用药病例比例为36.97%,不合理用药情况有:适应证不适宜、用法用量不适宜等。结论本院尖吻蝮蛇血凝不合理用药现象多见,应针对不合理用药原因采取干预措施,使临床用药合理。
OBJECTIVE To investigate the clinical application of Haemocoagulase Agkistrodon and promote its reasonable application.METHODS Selected 963 in-patientmedical records application of Haemocoagulase Agkistrodon in affiliated hospital from January 2019 to June 2019,filled in the comment form and evaluated the application of Haemocoagulase.RESULTS A total of 356 applications of Haemocoagulase Agkistrodon were irrational,the irrational use rate was 36.97%.There were many kinds of irrational Haemocoagulase Agkistrodon use,such as no indications,usage error.CONCLUSION The irrational Haemocoagulase Agkistrodon use in our hospital was serious,pharmaceutical intervention could be taken to promote that.
作者
张富东
朱敏凤
陈曦
胡利群
ZHANG Fu-dong;ZHU Min-feng;CHEN Xi;HU Li-qun(Leshan Vocational&Technical College,Leshan 614000,China;Leshan Food and Drug Testing Center,Leshan 614000,China;Affiliated Hospital of Leshan Vocational and Technical College,Leshan 614000,China)
出处
《海峡药学》
2020年第12期97-99,共3页
Strait Pharmaceutical Journal
基金
乐山市科技局软科学项目(编号18JRK005)
乐山职业技术学院教改项目(编号JG2018019)。
关键词
尖吻蝮蛇血凝酶
不合理用药
药学干预
Haemocoagulase Agkistrodon
Irrational Drug Use
Pharmaceutical
